Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
ClimateAI is an enterprise climate platform to help companies reduce, monitor, and adapt to physical climate risks. ClimateAi seeks to climate-proof the global economy while aiming for zero loss of lives, livelihoods, and nature. The company is a team of passionate entrepreneurs, scientists, and engineers who all believe that climate change is the most important problem of our generation.
Cohere is a platform that gives developers and businesses access to NLP, powered by the innovative generation of large language models. Cohere is used to build machines that understand the world and make it safely accessible to all. Cohere provides access to affordable, easy-to-deploy large language models. Its platform gives computers the ability to read and write.
Crossing Minds is the smartest platform powering perceptive recommendations that drive online discovery and engagement. Founded and led by world-renowned AI pioneers and powered by the latest advances in deep learning, Crossing Minds instantly delivers precise, session-based recommendations that don’t infringe on or jeopardize customer privacy. We help businesses engage their customers. We help people discover products they love. We help turn curiosity into loyalty.
DatologyAI is an AI-data curation startup that develops deep learning tools for automatic selection in data training. The company provides tools that help automate much of the creation of datasets. It identifies which information within a dataset is the most appropriate, based on what the AI model is designed to do. In addition, its tools can suggest ways to augment existing datasets with additional information, work out the best way to batch that information, or split it into more manageable chunks to streamline the model training process.
Genesis Therapeutics – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego – is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery.
Graft is a Modern AI platform enabling data teams to build production-ready AI solutions in a few clicks. No machine learning skills, no need to hire a team, and no infrastructure to build or maintain. Take a data-centric approach that leverages foundation models to drive better business outcomes today.